Johan Heylen
Chief Executive Officer at Sanofi Belgium NV
Profile
Presently, Johan Heylen occupies the position of Managing Director at Sanofi Belgium NV.
Mr. Heylen is also on the board of FlandersBio vzw.
Mr. Heylen previously occupied the position of Executive Director-Global Commercial at GlaxoSmithKline Plc and Chief Commercial Officer of Ablynx NV.
Mr. Heylen received an undergraduate degree from Katholieke Universiteit Leuven, an undergraduate degree from Hogeschool-Universiteit Brussel and an undergraduate degree from Solvay Business School of Economics & Management.
Johan Heylen active positions
Companies | Position | Start |
---|---|---|
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Director/Board Member | - |
Sanofi Belgium NV
Sanofi Belgium NV BiotechnologyHealth Technology Part of Sanofi, Sanofi Belgium NV is a Belgian company that produces and markets biological drugs. The private company is based in Diegem, Belgium. The company was founded in 1998. The CEO is Johan Heylen. | Chief Executive Officer | - |
Former positions of Johan Heylen
Companies | Position | End |
---|---|---|
GSK PLC | Corporate Officer/Principal | 2010-12-31 |
ABLYNX | Corporate Officer/Principal | - |
Training of Johan Heylen
Katholieke Universiteit Leuven | Undergraduate Degree |
Hogeschool-Universiteit Brussel | Undergraduate Degree |
Solvay Business School of Economics & Management | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GSK PLC | Health Technology |
Private companies | 3 |
---|---|
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Commercial Services |
Sanofi Belgium NV
Sanofi Belgium NV BiotechnologyHealth Technology Part of Sanofi, Sanofi Belgium NV is a Belgian company that produces and markets biological drugs. The private company is based in Diegem, Belgium. The company was founded in 1998. The CEO is Johan Heylen. | Health Technology |